Article info

Download PDFPDF

Original article
Persistence of low disease activity after tumour necrosis factor inhibitor (TNFi) discontinuation in patients with psoriatic arthritis

Authors

  1. Correspondence to Dr TA Boyd; tboyd9{at}uwo.ca
View Full Text

Citation

Huynh DH, Boyd TA, Etzel CJ, et al
Persistence of low disease activity after tumour necrosis factor inhibitor (TNFi) discontinuation in patients with psoriatic arthritis

Publication history

  • Received November 3, 2016
  • Accepted November 30, 2016
  • First published January 16, 2017.
Online issue publication 
January 16, 2017

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.